US Patent 8759516 Inhibitors of Bruton's tyrosine kinase
Patent 8759516 was granted and assigned to Pharmacyclics on June, 2014 by the United States Patent and Trademark Office.
All edits
Edits on 26 Sep, 2023
Golden AI
Edits made to:
Infobox (+3 properties)
Infobox
Patent Inventor Names
Erik Verner0
Lee Honigberg0
Zhengying Pan0
Edits on 14 Jun, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08759516 Inhibitors of Bruton's tyrosine kinase US Patent 8759516 Inhibitors of Bruton's tyrosine kinase
Infobox
Patent Number
08759516
Patent Number
8759516
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 19 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 23 Dec, 2021
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 08759516 Inhibitors of Bruton's tyrosine kinase
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
08759516
Date of patent
June 24, 2014
Patent application number
13952531
Date Filed
July 26, 2013
Patent primary examiner
Find more entities like US Patent 8759516 Inhibitors of Bruton's tyrosine kinase
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
